Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

Stroke; a Journal of Cerebral Circulation
T YamaguchiH Yasuhara

Abstract

The effect of ebselen, a seleno-organic compound with antioxidant activity through a glutathione peroxidase-like action, on the outcome of acute ischemic stroke was evaluated in a multicenter, placebo-controlled, double-blind clinical trial. Patients diagnosed as having acute ischemic stroke who could receive drug treatment within 48 hours of stroke onset were enrolled. Oral administration of ebselen granules suspended in water (150 mg BID) or placebo was started immediately after admission and was continued for 2 weeks. The major end points were the Glasgow Outcome Scale scores at 1 month and 3 months after the start of treatment. The modified Mathew Scale and modified Barthel Index scores at 1 month and 3 months were also studied as secondary outcome measures. Three hundred two patients were enrolled in the trial. Intent-to-treat analysis of 300 patients (151 given ebselen and 149 given placebo) revealed that ebselen treatment achieved a significantly better outcome than placebo at 1 month (P = .023, Wilcoxon rank sum test) but not at 3 months (P = .056, Wilcoxon rank sum test). The improvement was significant in patients who started ebselen within 24 hours of stroke onset but not in those who started treatment after 24 hours...Continue Reading

References

Mar 1, 1975·Lancet·B Jennett, M Bond
Jan 28, 1988·The New England Journal of Medicine·H J GelmersH J Wiezer
Jul 13, 1974·Lancet·G Teasdale, B Jennett
Jul 12, 1996·Biochemical Pharmacology·V UllrichF von Appen
Jan 1, 1996·The Journal of Pharmacy and Pharmacology·R NozawaH Masayasu
Jan 1, 1996·Chemical Research in Toxicology·H Masumoto, H Sies

❮ Previous
Next ❯

Citations

Jul 2, 2003·Neurotoxicity Research·P G Paterson, B H Juurlink
Mar 4, 2008·Journal of Physiology and Biochemistry·J JordánT Segura
Jul 2, 2011·Archives of Toxicology·Cristina W Nogueira, João B T Rocha
Sep 1, 2005·Journal of Neurology·K W Muir, Ph A Teal
Mar 17, 2010·Pflügers Archiv : European journal of physiology·Anthony Lau, Michael Tymianski
Dec 21, 2000·Current Atherosclerosis Reports·S H AhmedC Y Hsu
Jan 1, 2003·Current Neurology and Neuroscience Reports·Bruce OvbiageleJeffrey L Saver
Mar 1, 2008·Environmental Health and Preventive Medicine·Ujang Tinggi
Sep 10, 2013·Biochemical Pharmacology·Michael J Parnham, Helmut Sies
Mar 23, 2005·Brain Research·Fernanda Bossemeyer CenturiãoJoão Batista Teixeira Rocha
Nov 25, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J PerottoniT Emanuelli
Mar 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Mathew B PottsLinda J Noble-Haeusslein
Jun 15, 2005·Pharmacology, Biochemistry, and Behavior·Marilise E BurgerJoão B T Rocha
Sep 17, 2002·European Journal of Pharmacology·Lisiane O PorciúnculaDiogo O Souza
May 30, 2001·Advanced Drug Delivery Reviews·D MorinJ Tillement
Jan 29, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marilise E BurgerJoão B T Rocha
Feb 13, 2001·Neuroscience Letters·L O PorciúnculaD O Souza
Aug 6, 2000·Free Radical Biology & Medicine·H Sies, G E Arteel
Feb 28, 2002·Free Radical Biology & Medicine·Minjie ZhangKiyohisa Sekizawa
Dec 25, 2002·Free Radical Biology & Medicine·Hideaki ImaiIseabail Mhairi Macrae
Oct 13, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·K RejdakP Grieb
Sep 1, 2001·Environmental Toxicology and Pharmacology·G E Arteel, H Sies
May 16, 2006·Chemical Research in Toxicology·Honglian ShiKe Jian Liu
Jan 10, 2013·Nature Communications·Nisha SinghGrant C Churchill
Oct 21, 2009·Chemical Communications : Chem Comm·Rok SekirnikChristopher J Schofield
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jason HowittSeong-Seng Tan
May 19, 2007·Antioxidants & Redox Signaling·Laura Vanda PappKum Kum Khanna
Jun 5, 2008·Antioxidants & Redox Signaling·Dunyaporn TrachoothamPeng Huang
Sep 10, 2009·Antioxidants & Redox Signaling·Sarah K HartenPatrick H Maxwell
Nov 20, 2010·Antioxidants & Redox Signaling·Edith LubosDiane E Handy
Mar 18, 2006·Current Opinion in Critical Care·Michael GeogheganJeremy Powell-Tuck
Aug 2, 2007·Journal of Cardiovascular Pharmacology·Holly C Williams, Kathy K Griendling
Feb 15, 2000·Annals of the New York Academy of Sciences·A BoireauS Moussaoui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.